RADT-25. EVALUATING LYMPHOCYTE COUNTS IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION

BACKGROUND: Glioblastoma (GBM) patients are treated with chemotherapy, radiation therapy (RT) and often corticosteroids, which can all contribute to lymphopenia. We examined lymphopenia with respect to incidence, predictors, and association with progression-free survival (PFS) and overall survival (...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Hammoudeh, Lubna, Lim-Fat, Mary Jane, Cagney, Daniel, Aizer, Ayal A, Tanguturi, Shyam, Arvold, Nils, Mcfaline-Figueroa, Jose, Chukwueke, Ugonma, Reardon, David, Lee, Eudocia, Nayak, Lakshmi, Rinne, Mikael, Ligon, Keith, Wen, Patrick, Alexander, Brian, Rahman, Rifaquat
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Clinical Radiotherapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651411/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.778
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars